Skip to main content
Displaying 176 of 2902 articles.
>

In brief: A close look at how HIV-fighting proteins slow the virus down

A new study sheds light on how the body fights back against HIV by mutating the viral DNA.

New study points the way to therapy for rare cancer that targets the young

Scientists have engineered a mouse model to study a rare and often-fatal form of liver cancer. They’ve used it to clarify what drives these tumors at the molecular level, and discover new drug concepts.

In the fight against viral infection, spelling counts

Scientists have discovered a peculiarity in the genetic code of HIV that might explain how this and other viruses evolved ways to dodge our immune system. The findings could make it possible to develop safer vaccines.

Targeting a single protein might treat a broad range of viruses

Scientists have identified a protein that many viruses require to spread within a host—a discovery that could lead to fighting diseases as varied as parainfluenza, West Nile, and Zika with a single drug. This finding could also lead to the development of treatments for emerging viruses.

Potential new treatment for Fragile X targets one gene to affect many

Scientists found that inhibiting a regulatory protein alters the intricate signaling chemistry that is responsible for many of the disease’s symptoms. The findings provide a path to possible therapeutics for disorders associated with Fragile X.

Inflammation trains the skin to heal faster

Scientists have found that stem cells in the skin remember an injury, helping them close recurring wounds faster. The discovery could advance research and treatment of psoriasis and other inflammatory diseases.

Titia de Lange to receive 2017 Rosenstiel Award

de Lange is honored for her elucidation of the mechanism of telomere protection and the maintenance of genome stability.

Rockefeller University biologist Michael W. Young honored with Nobel Prize for pioneering studies on circadian rhythm

Rockefeller University biologist Michael W. Young, who studies the biological clocks that regulate sleep, metabolism, and response to disease, is this year’s recipient of the Nobel Prize in Physiology or Medicine.

>

In brief: Alternative CRISPR system is less specific, more robust

Scientists found that a system called CRISPR-Cas10 can target rapidly mutating viruses.

Albany Medical Center Prize awarded to Luciano Marraffini

The prestigious award honors Marraffini and four other scientists for development of the revolutionary genome-editing system known as CRISPR-Cas9.